Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis

• REFERENCES

• 1 Bleyer WA, Hakami N, Shepard TH. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971; 79: 838-853
• 2 Hathaway WE, Bonnar J. Perinatal Coagulation. Grune and Stratton, NewYork 1978
• 3 Corrigan Jr JJ. Normal hemostasis in fetus and newborn. Coagulation. In: Neonatal and Fetal Medicine Physiology and Pathophysiology. Polin RA, Fox WW. eds Grune and Stratton; New York: in press
• 4 Hathaway WE, Bonnar J. Hemostatic Disorders of the Pregnant Woman and Newborn Infant. Elsevier Science Publishing Co; New York: 1987
• 5 Henriksson P, Hedner U, Nilsson IM, Boehm J, Robertson B, Lorand L. Fibrin stabilizingfactor (factor XIII) in the fetus and the newborn infant. Pediatr Res 1974; 8: 789-791
• 6 Beverley DW, Inwood MJ, Chance GW, Schaus M, O’Keefe B. Normal haemostasis parameters: a study in a well-defined inborn population of preterm infants. Early Human Dev 1984; 9: 249-257
• 7 Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13: 1330-1335
• 8 Schettini E, De Mattia D, Altomare M, Montagna O, Ciavarella G, Manzionna MM. Post-natal development of protein C in full-term newborns. Acta Paediatr Scand 1985; 74: 226-229
• 9 Peters M, ten Cate JW, Jansen E, Breederveld C. Coagulation and fibrinolytic factors in the first week of life in healthy infants. J Pediatr 1985; 106: 292-295
• 10 Yamada K, Shirahata A, Meguro T. The comparative studies on factor XIII of newborn infants obtained by three methods; clot solubility, immunological and fluorescent assays. Acta Haematol Jpn 1976; 39: 79-84
• 11 Karpatkin M, Mannucci PM, Bhogal M, Vigano S, Nardi M. Low protein C in the neonatal period. Br J Haematol 1986; 62: 137-142
• 12 Polack B, Pouzol R, Amiral J, Kolodie L. Protein C level at birth. Thromb Haemostas 1984; 52: 188-191
• 13 Mibashan RS, Millar DS. Fetal haemophilia and allied bleeding disorders. Br Med Bull 1983; 39: 393-398
• 14 Holmberg L, Henriksson P, Ekelund H, Astedt B. Coagulation in the human fetus: comparison with term newborn infants. J Pediatr 1974; 85: 860-864
• 15 Ekelund H, Hedner U, Astedt B. Fibrinolysis in human foetuses. Acta Paediatr Scand 1970; 59: 369-376
• 16 Ekelund H, Hedner U, Nilsson IM. Fibrinolysis in newborns. Acta Paediatr Scand 1970; 59: 33-43
• 17 Terwiel J, Veltkamp JJ, Bertina RM, Muller HP. Coagulation factors in the human fetus of about 20 weeks of gestational age. Br J Haematol 1980; 45: 641-650
• 18 Andrew M, Massicotte-Nolan P, Mitchell L, Cassidy K. Dysfunctional antithrombin III in sick premature infants. Pediatr Res 1985; 19: 237-239
• 19 Schettini AU, De-Mattia E, Altomare D, Montagna M. Post-natal development of factor IX. Acta Paediatr Scand 1980; 69: 53-58
• 20 Johnson SS, Montgomery RR, Hathaway WE. Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. Br J Haematol 1981; 47: 597-606
• 21 Gordon EM, Ratnoff OD, Saito H, Gross S, Jones PK. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn. Am J Pediatr Hematol 1980; 02 (03) 213-216
• 22 Andrew M, Bhogal M, Karpatkin M. Factors XI and XII and prekallikrein in sick and healthy premature infants. N Engl J Med 1981; 305 (19) 1130-1133
• 23 Ekelund H, Finnstrom O. Fibrinolysis in pre-term infants and in infants small for gestational age. Acta Paediatr Scand 1972; 61: 185-196
• 24 Yamada K, Yamada Z. Active and potentially active forms of fibrin stabilizing factor (factor XIII) in various disorders and in neonatal infants. J Med 1968; 17 (02) 125-133
• 25 Sell EJ, Corrigan Jr JJ. Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gestational age. J Pediatr 1973; 82: 1028-1032
• 26 Corrigan Jr JJ, Sell EJ, Pagel C. Hageman factor and disseminated intravascular coagulation (DIC) in newborn and rabbits. Pediatr Res 1977; ll: 916-920
• 27 Manco-Johnson M, Marlar R, Jacobson L, Hays T, Warady BA. Severe protein C deficiency in newborn infants. J Pediatr 1988; 113: 359-363
• 28 Johnston M, Zipursky A. Microtechnology for the study of the blood coagulation system in newborn infants. In: Acquired Bleeding Disorders in Children Platelet Abnormalities and Laboratory Methods. Lusher JM, Barnhart MI. eds Masson, New York: 1981: 33-147
• 29 Terwiel J, Veltkamp JJ, Bertina RM, van der Linden I, van Tilburg NH. Coagulation factors in the premature infant born after about 32 weeks of gestation. Biol Neonate 1985; 47: 9-18
• 30 Schwarz HP, Munteen W, Watzke H, Richter B, Griffin JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988; 7l: 562-565
• 31 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the fullterm infant. Blood 1987; 70: 765-772
• 32 Andrew M, Paes B, Milner R, Johnstoo M, Mitchell L, Tollefsen DM, Castel V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 165l-1657
• 33 Dube B, Dube RK, Bhargava K, Kolindewala JK, Kota VLN, Das BK. Hemostatic parameters in newborn. - I. Effect of gestation and rate of intrauterine growth. Thromb Haemostas 1986 55. 47-50
• 34 Ziptrsky A, deSa D, Hsu E, Johnston M, Milner R. Clinical and laboratory diagnosis of hemostatic disorders in newborn infants. Am J Pediatr Hematol Oncol 1979; 1: 217-226
• 35 Arbol P, Bhargavz V, Dube B, Tiwari AD, Sharma A. Hemostasis in healthy neonates. Indian Pediatr 1984; 2l: 671-675
• 36 Kolindewala JK, Dube B, Bhargava V, Dube RK, Kota VLN, Das BK. Hemostatic parameters in newborn, - II. Sequential study during the first four weeks of life. Thromb Haemostas 1986; 55: 51-53